SNOT-22 quality of life domains differentially predict treatment modality selection in chronic rhinosinusitis

Adam S. Deconde, Jess C. Mace, Todd Bodner, Peter H. Hwang, Luke Rudmik, Zachary M. Soler, Timothy Smith

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Background: Prior study demonstrated that baseline 22-item Sino-Nasal Outcome Test (SNOT-22) aggregate scores accurately predict selection of surgical intervention in patients with chronic rhinosinusitis (CRS). Factor analysis of the SNOT-22 survey has identified five distinct domains that are differentially impacted by endoscopic sinus surgery (ESS). This study sought to quantify SNOT-22 domains in patient cohorts electing both surgical or medical management and postinterventional change in these domains. Methods: CRS patients were prospectively enrolled into a multi-institutional, observational cohort study. Subjects elected continued medical management or ESS. SNOT-22 domain scores at baseline were compared between treatment cohorts. Postintervention domain score changes were evaluated in subjects with at least six-month follow-up. Results: A total of 363 subjects were enrolled with 72 (19.8%) electing continued medical management, whereas 291 (80.2%) elected ESS. Baseline SNOT-22 domain scores were comparable between treatment cohorts in sinus-specific domains (rhinologic, extranasal rhinologic, and ear/facial symptoms; p > 0.050); however, the surgical cohort reported significantly higher psychological (mean ± standard deviation [SD]: 16.0 ± 8.4 vs 12.0 ± 7.1; p <0.001) and sleep dysfunction (13.7 ± 6.8 vs 10.5 ± 6.2; p <0.001) than the medical cohort. Effect sizes for ESS varied across domains with rhinologic and extranasal rhinologic symptoms experiencing the greatest gains (1.067 and 0.997, respectively), whereas psychological and sleep dysfunction experiencing the smallest improvements (0.805 and 0.818, respectively). Patients experienced greater mean improvements after ESS in all domains compared to medical management (p <0.001). Conclusion: Subjects electing ESS report higher sleep and psychological dysfunction compared to medical management but have comparable sinus-specific symptoms. Subjects undergoing ESS experience greater gains compared to medical management across all domains; however, these gains are smallest in the psychological and sleep domains.

Original languageEnglish (US)
Pages (from-to)972-979
Number of pages8
JournalInternational Forum of Allergy and Rhinology
Volume4
Issue number12
DOIs
StatePublished - Dec 1 2014

Fingerprint

Quality of Life
Sleep
Psychology
Therapeutics
Nose
Statistical Factor Analysis
Observational Studies
Ear
Cohort Studies

Keywords

  • Endoscopy
  • Outcome assessment
  • Quality of life
  • Sinusitis
  • Therapeutics

ASJC Scopus subject areas

  • Immunology and Allergy
  • Otorhinolaryngology

Cite this

SNOT-22 quality of life domains differentially predict treatment modality selection in chronic rhinosinusitis. / Deconde, Adam S.; Mace, Jess C.; Bodner, Todd; Hwang, Peter H.; Rudmik, Luke; Soler, Zachary M.; Smith, Timothy.

In: International Forum of Allergy and Rhinology, Vol. 4, No. 12, 01.12.2014, p. 972-979.

Research output: Contribution to journalArticle

Deconde, Adam S. ; Mace, Jess C. ; Bodner, Todd ; Hwang, Peter H. ; Rudmik, Luke ; Soler, Zachary M. ; Smith, Timothy. / SNOT-22 quality of life domains differentially predict treatment modality selection in chronic rhinosinusitis. In: International Forum of Allergy and Rhinology. 2014 ; Vol. 4, No. 12. pp. 972-979.
@article{a3302a8642e646179b17b17312ea3693,
title = "SNOT-22 quality of life domains differentially predict treatment modality selection in chronic rhinosinusitis",
abstract = "Background: Prior study demonstrated that baseline 22-item Sino-Nasal Outcome Test (SNOT-22) aggregate scores accurately predict selection of surgical intervention in patients with chronic rhinosinusitis (CRS). Factor analysis of the SNOT-22 survey has identified five distinct domains that are differentially impacted by endoscopic sinus surgery (ESS). This study sought to quantify SNOT-22 domains in patient cohorts electing both surgical or medical management and postinterventional change in these domains. Methods: CRS patients were prospectively enrolled into a multi-institutional, observational cohort study. Subjects elected continued medical management or ESS. SNOT-22 domain scores at baseline were compared between treatment cohorts. Postintervention domain score changes were evaluated in subjects with at least six-month follow-up. Results: A total of 363 subjects were enrolled with 72 (19.8{\%}) electing continued medical management, whereas 291 (80.2{\%}) elected ESS. Baseline SNOT-22 domain scores were comparable between treatment cohorts in sinus-specific domains (rhinologic, extranasal rhinologic, and ear/facial symptoms; p > 0.050); however, the surgical cohort reported significantly higher psychological (mean ± standard deviation [SD]: 16.0 ± 8.4 vs 12.0 ± 7.1; p <0.001) and sleep dysfunction (13.7 ± 6.8 vs 10.5 ± 6.2; p <0.001) than the medical cohort. Effect sizes for ESS varied across domains with rhinologic and extranasal rhinologic symptoms experiencing the greatest gains (1.067 and 0.997, respectively), whereas psychological and sleep dysfunction experiencing the smallest improvements (0.805 and 0.818, respectively). Patients experienced greater mean improvements after ESS in all domains compared to medical management (p <0.001). Conclusion: Subjects electing ESS report higher sleep and psychological dysfunction compared to medical management but have comparable sinus-specific symptoms. Subjects undergoing ESS experience greater gains compared to medical management across all domains; however, these gains are smallest in the psychological and sleep domains.",
keywords = "Endoscopy, Outcome assessment, Quality of life, Sinusitis, Therapeutics",
author = "Deconde, {Adam S.} and Mace, {Jess C.} and Todd Bodner and Hwang, {Peter H.} and Luke Rudmik and Soler, {Zachary M.} and Timothy Smith",
year = "2014",
month = "12",
day = "1",
doi = "10.1002/alr.21408",
language = "English (US)",
volume = "4",
pages = "972--979",
journal = "International Forum of Allergy and Rhinology",
issn = "2042-6976",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - SNOT-22 quality of life domains differentially predict treatment modality selection in chronic rhinosinusitis

AU - Deconde, Adam S.

AU - Mace, Jess C.

AU - Bodner, Todd

AU - Hwang, Peter H.

AU - Rudmik, Luke

AU - Soler, Zachary M.

AU - Smith, Timothy

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Background: Prior study demonstrated that baseline 22-item Sino-Nasal Outcome Test (SNOT-22) aggregate scores accurately predict selection of surgical intervention in patients with chronic rhinosinusitis (CRS). Factor analysis of the SNOT-22 survey has identified five distinct domains that are differentially impacted by endoscopic sinus surgery (ESS). This study sought to quantify SNOT-22 domains in patient cohorts electing both surgical or medical management and postinterventional change in these domains. Methods: CRS patients were prospectively enrolled into a multi-institutional, observational cohort study. Subjects elected continued medical management or ESS. SNOT-22 domain scores at baseline were compared between treatment cohorts. Postintervention domain score changes were evaluated in subjects with at least six-month follow-up. Results: A total of 363 subjects were enrolled with 72 (19.8%) electing continued medical management, whereas 291 (80.2%) elected ESS. Baseline SNOT-22 domain scores were comparable between treatment cohorts in sinus-specific domains (rhinologic, extranasal rhinologic, and ear/facial symptoms; p > 0.050); however, the surgical cohort reported significantly higher psychological (mean ± standard deviation [SD]: 16.0 ± 8.4 vs 12.0 ± 7.1; p <0.001) and sleep dysfunction (13.7 ± 6.8 vs 10.5 ± 6.2; p <0.001) than the medical cohort. Effect sizes for ESS varied across domains with rhinologic and extranasal rhinologic symptoms experiencing the greatest gains (1.067 and 0.997, respectively), whereas psychological and sleep dysfunction experiencing the smallest improvements (0.805 and 0.818, respectively). Patients experienced greater mean improvements after ESS in all domains compared to medical management (p <0.001). Conclusion: Subjects electing ESS report higher sleep and psychological dysfunction compared to medical management but have comparable sinus-specific symptoms. Subjects undergoing ESS experience greater gains compared to medical management across all domains; however, these gains are smallest in the psychological and sleep domains.

AB - Background: Prior study demonstrated that baseline 22-item Sino-Nasal Outcome Test (SNOT-22) aggregate scores accurately predict selection of surgical intervention in patients with chronic rhinosinusitis (CRS). Factor analysis of the SNOT-22 survey has identified five distinct domains that are differentially impacted by endoscopic sinus surgery (ESS). This study sought to quantify SNOT-22 domains in patient cohorts electing both surgical or medical management and postinterventional change in these domains. Methods: CRS patients were prospectively enrolled into a multi-institutional, observational cohort study. Subjects elected continued medical management or ESS. SNOT-22 domain scores at baseline were compared between treatment cohorts. Postintervention domain score changes were evaluated in subjects with at least six-month follow-up. Results: A total of 363 subjects were enrolled with 72 (19.8%) electing continued medical management, whereas 291 (80.2%) elected ESS. Baseline SNOT-22 domain scores were comparable between treatment cohorts in sinus-specific domains (rhinologic, extranasal rhinologic, and ear/facial symptoms; p > 0.050); however, the surgical cohort reported significantly higher psychological (mean ± standard deviation [SD]: 16.0 ± 8.4 vs 12.0 ± 7.1; p <0.001) and sleep dysfunction (13.7 ± 6.8 vs 10.5 ± 6.2; p <0.001) than the medical cohort. Effect sizes for ESS varied across domains with rhinologic and extranasal rhinologic symptoms experiencing the greatest gains (1.067 and 0.997, respectively), whereas psychological and sleep dysfunction experiencing the smallest improvements (0.805 and 0.818, respectively). Patients experienced greater mean improvements after ESS in all domains compared to medical management (p <0.001). Conclusion: Subjects electing ESS report higher sleep and psychological dysfunction compared to medical management but have comparable sinus-specific symptoms. Subjects undergoing ESS experience greater gains compared to medical management across all domains; however, these gains are smallest in the psychological and sleep domains.

KW - Endoscopy

KW - Outcome assessment

KW - Quality of life

KW - Sinusitis

KW - Therapeutics

UR - http://www.scopus.com/inward/record.url?scp=84918791957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84918791957&partnerID=8YFLogxK

U2 - 10.1002/alr.21408

DO - 10.1002/alr.21408

M3 - Article

C2 - 25323055

AN - SCOPUS:84918791957

VL - 4

SP - 972

EP - 979

JO - International Forum of Allergy and Rhinology

JF - International Forum of Allergy and Rhinology

SN - 2042-6976

IS - 12

ER -